CClinicalTrials.gg
CompletedNCT06194084DURIOMEUpdated Oct 1, 2025

Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers

An interventional study of Two-sequence of durian pulp doses (100 g and 200 g) in Diet, Food and Nutrition, sponsored by National Cancer Centre, Singapore. Completed at 1 site in Singapore. Open to participants aged 21 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by National Cancer Centre, Singapore · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Feb 2023, registered Nov 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
45
Allocation
Not applicable
Ages
21 Years to 60 Years
Sex
All
01

Study summary

This clinical study investigates the impacts of daily durian consumption on gut microbiota, gut microbial metabolites, and host metabolome in healthy individuals.

Read the detailed description

Participants will go through an initial washout maintaining a low-fiber diet for 14 days. After washout, participants will be instructed to consume 100 grams of durian pulp every day following their breakfast or dinner for 1 week. Participants will then continue to consume 200 grams of durian pulp every day during the 2nd week of intervention and then will go through another washout for 2 weeks. During the intervention period, participants will be informed to maintain low-fiber diet. All participants will be required to note down their stool consistency and stool frequency and 3-days dietary records. Stool and blood samples will be collected at 4 time points during the study period (baseline, 1-week of intervention, 2-weeks of intervention and 2-weeks washout) and will be stored at -80 °C until analysis.

The first outcomes of this study will provide insights into the interplay between durian consumption, gut microbiome, and host metabolome, as well as whether durian consumption can improve the clinical parameters (plasma glucose levels, lipid profiles and HbA1c levels) of healthy subjects. The interplay between diets, gut microbiome, host metabolome and genetic polymorphism data in healthy population will lay the groundwork to develop the precision nutrition strategy based on our regional food. These findings have potential to improve the health and well-being of the communities in our region.

02

Conditions studied

  • Diet, Food and Nutrition

Keywords

  • Precision Nutrition
  • Durian
  • Gut Microbiome
  • Metabolome
03

In context

Lead sponsor

National Cancer Centre, Singapore is the lead sponsor of 116 studies on the registry; 30 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Male and/or female subjects between the ages of 21 and 60 years, inclusive
  2. Willing and able to provide written informed consent
  3. Must be in generally good health with clinically insignificant screening results (Fasting plasma glucose level \& Lipid profile), as determined by the Investigator
  4. Agrees to consume durian for 2 weeks
  5. Agrees to maintain a low-fiber diet during the intervention
  6. Have not received any antibiotics therapy, consumed prebiotics, probiotics, symbiotic /vitamin supplement, and/or TCM for at least 1 month before the start of the study
  7. Have not received any medical treatment that would impact on intestinal microbiota at least 6 months before the start of the study or during the study
  8. Recent COVID-19 vaccination received or infection with COVID-19 at least 2 months ago

Exclusion criteria

Exclusion Criteria:

  1. Known or suspected sensitivity/allergy to durian
  2. Multiple food/drug allergies
  3. Smoker
  4. History or presence of current metabolic conditions and gastrointestinal diseases
  5. Diagnosed with Inflammatory Bowel Disease (IBD) or significant liver enzyme abnormality
  6. Presence of current haemorrhoids or piles causing rectal bleeding when passing stool
  7. Pregnant, breastfeeding or intending to conceive during study period
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
45 participants (actual)

Study arms

  • Experimental
    Intervention - durian pulp.

    Two-sequence of doses (100 g and 200 g) of durian pulp.

    Other: Two-sequence of durian pulp doses (100 g and 200 g)

Interventions

  • OtherTwo-sequence of durian pulp doses (100 g and 200 g)

    Participants first go through an initial washout maintaining a low-fiber diet for 14 days. After washout, participants will be instructed to consume 100 grams of durian pulp every day following their breakfast or dinner for 1 week. Participants will then continue to consume 200 grams of durian pulp every day during the 2nd week of intervention and then will go through another washout for 2 weeks.

06

What researchers measure

Primary outcomes

  1. Fasted Blood Glucose

    Changes in Fasted Blood Glucose (mg/dL), before \& after Durian intervention.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  2. HbA1C

    Changes in HbA1C (%) before \& after Durian intervention.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  3. Total Cholesterol

    Changes in Total Cholesterol (mg/dL) before \& after Durian Intervention.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  4. HDL Cholesterol

    Changes in HDL Cholesterol (mg/dL) before \& after Durian intervention.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  5. LDL Cholesterol

    Changes in LDL Cholesterol (mg/dL) before \& after Durian intervention.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  6. Cholesterol/HDL Ratio

    Changes in Cholesterol/HDL ratio before \& after Durian intervention.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  7. Triglycerides

    Changes in Triglycerides (mg/dL) before \& after Durian intervention.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  8. Carbohydrates

    Food record for carbohydrate intake.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  9. Protein

    Food record for protein intake.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  10. Fats

    Food record for fat intake.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  11. Dietary Fibre

    Food record for dietary fibre intake.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  12. Cholesterol

    Food record for cholesterol intake.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  13. Sodium

    Food record for sodium intake.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  14. Sugar

    Food record for sugar intake.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

Secondary outcomes

  1. Changes in gut microbiome composition before and after Intervention.

    The effect of intervention on alpha and beta diversity of the fecal microbial community will be evaluated by 16s sequencing (using illumina MiSeq platforms) of feal bacterial DNA at baseline and after each intervention period.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

  2. Changes in metabolomes before and after Intervention.

    Changes in the plasma metabolomics will be evaluated via LC-QTOF-MS to identify the metabolomic markers at baseline and after each intervention period. Whereas changes in fecal microbial metabolomic will be determined via GC-QTOF-MS at baseline and after each intervention period.

    Time frame: Baseline, 1 week after Intervention (100gm of durian consumption), 2 weeks after Intervention (200gm of durian consumption), Post-Intervention Wash-out (2 weeks after intervention).

Other outcomes

  1. Plasma Samples obtained from 50 healthy participants form different multi-ethnicity (Malays, Chinese and Indians) will be genotyped using a custom single nucleotide polymorphism (SNP) genotyping array (Illumina OncoArray-500K Bead Chip).

    The association between the SNP in distinct ethnic groups and gut microbiome patterns will be investigated.

    Time frame: Baseline.

07

Study locations

1 site
  • National Cancer Centre, Singapore
    Singapore, 168583, Singapore
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06194084
Lead sponsor
National Cancer Centre, Singapore
Responsible party
Sponsor
First posted
Jan 8, 2024
Start date
Feb 1, 2023
Primary completion
Aug 29, 2025
Completion
Aug 29, 2025
Last update
Oct 1, 2025

Study contacts

Jason YS CHAN, MD, PhD
principal investigator · National Cancer Centre, Singapore

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion